Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4570543
Max Phase: Preclinical
Molecular Formula: C26H43N5O19
Molecular Weight: 729.65
Molecule Type: Unknown
Associated Items:
ID: ALA4570543
Max Phase: Preclinical
Molecular Formula: C26H43N5O19
Molecular Weight: 729.65
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H](OCN=[N+]=[N-])O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO[C@]3(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H](O)[C@H](O)[C@H]2O)[C@@H]1O
Standard InChI: InChI=1S/C26H43N5O19/c1-8(34)29-14-10(36)3-26(25(43)44,50-22(14)16(38)11(37)4-32)46-6-13-17(39)19(41)20(42)24(48-13)49-21-12(5-33)47-23(45-7-28-31-27)15(18(21)40)30-9(2)35/h10-24,32-33,36-42H,3-7H2,1-2H3,(H,29,34)(H,30,35)(H,43,44)/t10-,11+,12+,13+,14+,15+,16+,17-,18+,19-,20+,21+,22+,23+,24-,26+/m0/s1
Standard InChI Key: FEXHSACBVXHGJC-WBZWEQEOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 729.65 | Molecular Weight (Monoisotopic): 729.2552 | AlogP: -6.79 | #Rotatable Bonds: 15 |
Polar Surface Area: 381.71 | Molecular Species: ACID | HBA: 19 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 24 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -10.37 | CX Basic pKa: | CX LogP: -6.51 | CX LogD: -10.11 |
Aromatic Rings: 0 | Heavy Atoms: 50 | QED Weighted: 0.04 | Np Likeness Score: 1.46 |
1. Wu HR, Anwar MT, Fan CY, Low PY, Angata T, Lin CC.. (2019) Expedient assembly of Oligo-LacNAcs by a sugar nucleotide regeneration system: Finding the role of tandem LacNAc and sialic acid position towards siglec binding., 180 [PMID:31351394] [10.1016/j.ejmech.2019.07.046] |
Source(1):